Question

In: Biology

How could you show that the adaptor protein AP2 has a phosphatidylinositol-4,5-bisphosphate (PIP2) binding domain? In...

How could you show that the adaptor protein AP2 has a phosphatidylinositol-4,5-bisphosphate (PIP2) binding domain?

In like a simple-ish explanation please.

Solutions

Expert Solution

The clathrin adaptor complex AP-2 serves to coordinate clathrin-coated pit assembly with the sorting of transmembrane cargo proteins at the plasmalemma. How precisely AP-2 assembly and cargo protein recognition at sites of endocytosis are regulated has remained unclear, but recent evidence implicates phosphoinositides, in particular phosphatidylinositol (4,5)-bisphosphate (PI[4,5]P2), in these processes. Here we have identified and functionally characterized a conserved binding site for PI(4,5)P2 within μ2-adaptin, the medium chain of the clathrin adaptor complex AP-2. Mutant μ2 lacking a cluster of conserved lysine residues fails to bind PI(4,5)P2 and to compete the recruitment of native clathrin/AP-2 to PI(4,5)P2-containing liposomes or to presynaptic membranes. Moreover, we show that expression of mutant μ2 inhibits receptor-mediated endocytosis in living cells. We suggest that PI(4,5)P2 binding to μ2-adaptin regulates clathrin-mediated endocytosis and thereby may contribute to structurally linking cargo recognition to coat formation.

The AP2 clathrin adaptor complex links protein cargo to the endocytic machinery but it is unclear how AP2 is activated on the plasma membrane. Here we demonstrate that the membrane-associated proteins FCHo and SGIP1 convert AP2 into an open, active conformation. We screened for Caenorhabditis elegans mutants that phenocopy the loss of AP2 subunits and found that AP2 remains inactive in fcho-1 mutants. A subsequent screen for bypass suppressors of fcho-1 nulls identified 71 compensatory mutations in all four AP2 subunits. Using a protease-sensitivity assay we show that these mutations restore the open conformation in vivo. The domain of FCHo that induces this rearrangement is not the F-BAR domain or the µ-homology domain, but rather is an uncharacterized 90 amino acid motif, found in both FCHo and SGIP proteins, that directly binds AP2. Thus, these proteins stabilize nascent endocytic pits by exposing membrane and cargo binding sites on AP2.


Related Solutions

A biochemist replaces the DNA‐binding domain of the yeast Gal4 protein with the DNA‐binding domain of...
A biochemist replaces the DNA‐binding domain of the yeast Gal4 protein with the DNA‐binding domain of the Lac repressor and finds that the engineered protein no longer regulates transcription of the GAL genes in yeast. A. Draw a diagram of the different functional domains you would expect to find in the Gal4 protein and in the engineered protein. B. What might be done to the DNA‐binding site recognised by this chimeric protein to make it functional in activating transcription of...
If you were to replace the DNA-binding domain of the Yeast Gal4 protein with the DNA...
If you were to replace the DNA-binding domain of the Yeast Gal4 protein with the DNA binding domain from the Lac repressor, this protein would no longer regulate the transcription of GAL genes in yeast. A: Draw two different modular diagrams (just pairs of labeled rectangles of domains) of the different functional domains you would expect to find in the Gal4 protein and in the engineered protein. B: Why does the engineered protein no longer regulate transcription of the GAL...
How do we get from a ligand binding to a heterotrimeric GTP-binding protein to the activation...
How do we get from a ligand binding to a heterotrimeric GTP-binding protein to the activation of PKA?
compare and contrast PIP2, PIP3 and IP3 and show/explain how to get each one in details
compare and contrast PIP2, PIP3 and IP3 and show/explain how to get each one in details
how to increase a binding between a ligand ( etravirine) and a protein ( Human immunodeficiency...
how to increase a binding between a ligand ( etravirine) and a protein ( Human immunodeficiency virus type 1 HIV-1). disscusion should be based on thermodynamic theory
graph the function A. Show steps how you find the domain, the x and y-intercepts, the...
graph the function A. Show steps how you find the domain, the x and y-intercepts, the horizontal and vertical asymptotes, the intervals of increasing and decreasing, the relative extrema, the intervals of concave up and down, all critical points, all inflection points, and any test points you use. then graph function A= 1-X/e^- X
How would a mutation in the lac repressor protein that was missing the effector binding site...
How would a mutation in the lac repressor protein that was missing the effector binding site behave in E. coli in the presence and absence of lactose? Would it produce B=-galactosidase?
Could you show me how to convert this problem? A physician has ordered 5600 mg of...
Could you show me how to convert this problem? A physician has ordered 5600 mg of penicillin V, intramuscularly. If penicillin V were available as 0.80 g/mL of solution, how many milliliters would you need to give?
How could you show that adherent phenotype was influenced by RpoS?
How could you show that adherent phenotype was influenced by RpoS?
1. Align human cardiac and skeletal isoforms of human myosin-binding protein C. Show alignment. Where these...
1. Align human cardiac and skeletal isoforms of human myosin-binding protein C. Show alignment. Where these isoforms differ most of all from each other? 2. Predict secondary structure of the region where isoforms are most different. Do you think if it is disordered region or if it has compact tertiary structure?
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT